FT596

· Fate Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FT596, covering 2024-07-09 to 2024-07-09. Get the full timeline:

Most recent: Clinical Trial Update: FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL [Phase 1]